/stackumbrella/media/media_files/wp-content/uploads/2020/11/feature-image-3rd9.jpg)
The Indian government has signed a deal with "Serum Institute of India,"Bangladesh, and Beximco Pharmaceuticals on Thursday. Read further to know about this deal and how both the countries will get benefit from this deal.
About The India-Bangladesh Deal
/stackumbrella/media/media_files/wp-content/uploads/2020/11/413fcc3f783db834937ee9de7912bc1e6ed3c22f.jpg)
The same is confirmed by Zahid Maleque who is the health minister of Bangladesh. He further said Bangladesh will buy every month from India once it successfully passes all the trials.
The vaccine is considered safe and effective but questions have been raising on its effectiveness after a manufacturing error came.
The error came soon after the Oxford University and Serum Institute announced that AstraZeneca is highly effective. But, the officials of the Institute said the vaccine is 60-70 percent effective against the virus so there is nothing to panic about.
Every country is waiting eagerly for the vaccine and PM Narendra Modi has advised the world to be united in this fight. Together we can fight this disaster.
Also Read: Shocking! Poor Beggar Donates This Unbelievable Amount in Covid-19 Care Fund
After Bangladesh, countries like South Korea, Austria, Bhutan, Qatar, Myanmar, Bahrain, and Switzerland are also interested in India's vaccine development.
/stackumbrella/media/agency_attachments/2026/02/03/2026-02-03t122236880z-logo_5ec00731b6678-2026-02-03-17-52-36.png)
Follow Us